Weak-Base Induced Lysosomal Secretion by Macrophages: An Alternative Trigger Mechanism that is Independent of Complement Activation

  • David W. H. Riches
  • Denis R. Stanworth
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 155)


The abundance of mononuclear phagocytes at inflammatory sites has stimulated much interest in their pathological roles. In vitro investigations have indicated that these cells are amply equipped to promote an inflammatory response, following suitable stimulation, by the synthesis and secretion of a variety of biologically active products such as complement proteins (1), prostaglandins (2), neutral proteinases (3,4), and lysosomal acid hydrolases (5,6,7). Whereas the nature of these secretory products has been well characterized, the biochemical pathways underlying the triggering of their release remain only poorly understood.


Phenylmethylsulphonyl Fluoride Zymosan Particle Serine Esterase Hexose Monophosphate Shunt Lysosomal Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bentley, C., Fries, W., and Brade, V., Immunology 35:971, 1978.PubMedGoogle Scholar
  2. 2.
    Bonney, R. J., Wightman, P. D., Davies, P., Sadowski, S. J., Kuehl, F. A., and Humes, J. L., Biochem. J. 176:433, 1978.PubMedGoogle Scholar
  3. 3.
    Werb, Z., and Gordon, S., J. Exp. Med. 142:346, 1974.CrossRefGoogle Scholar
  4. 4.
    Unkeless, J. C., Gordon, S., and Reich, E., J. Exp. Med. 139:834, 1974.PubMedCrossRefGoogle Scholar
  5. 5.
    Cardella, C. J., Davies, P., and Allison, A. C., Nature 247:46, 1974.PubMedCrossRefGoogle Scholar
  6. 6.
    Schorlemmer, H. U., Edwards, J. H., Davies, P., and Allison, A. C., Clin. Exp. Immunol. 27:198, 1977.PubMedGoogle Scholar
  7. 7.
    Schnyder, J., and Baggiolini, M., J. Exp. Med. 148:435, 1978.PubMedCrossRefGoogle Scholar
  8. 8.
    Riches, D. W. H., and Stanworth, D. R., Immunology 44:29, 1981.PubMedGoogle Scholar
  9. 9.
    Schorlemmer, H. U., Bitter-Suermann, D., and Allison, A. C., Immunology 32:929, 1977.PubMedGoogle Scholar
  10. 10.
    Schorlemmer, H. U., Davies, P., and Allison, A. C., Nature 261:48, 1976.PubMedCrossRefGoogle Scholar
  11. 11.
    Riches, D. W. H., and Stanworth, D. R., Biochem. J. 188:933, 1980.PubMedGoogle Scholar
  12. 12.
    von Zabern, I., Nolte, R., and Vogt, W., J. Immunol. 124:1543, 1980.Google Scholar
  13. 13.
    Pangburn, M. K., and Muller-Eberhard, H. J., J. Exp. Med. 152:1102, 1980.PubMedCrossRefGoogle Scholar
  14. 14.
    Riches, D. W. H., Morris, C. J., and Stanworth, D. R., Biochem. Pharmacol. 30:629, 1981.PubMedCrossRefGoogle Scholar
  15. 15.
    Riches, D. W. H., and Stanworth, D. R., Biochem. J. 202:639, 1982.PubMedGoogle Scholar
  16. 16.
    de Duve, C., de Barsy, T., Poole, B., Trouet, A., Tulkens, P., and van Hoof, F., Biochem. Pharmacol. 23:2495, 1974.PubMedCrossRefGoogle Scholar
  17. 17.
    Riches, D. W. H., and Stanworth, D. R., Immunol. Letts. 1:363, 1980.CrossRefGoogle Scholar
  18. 18.
    Czop, J. K., Fearon, D. T., and Austen, K. F., J. Immunol. 120:1132, 1978.PubMedGoogle Scholar
  19. 19.
    Weir, D. M., and Ogmundsdottir, H. M., Clin. Exp. Immunol. 30:323, 1977.PubMedGoogle Scholar
  20. 20.
    Riches, D. W. H., Morris, C. J., and Stanworth, D. R., Immunology 45:473, 1982.PubMedGoogle Scholar
  21. 21.
    Ohkuma, S., and Poole, B., J. Cell Biol. 90:656, 1981.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • David W. H. Riches
    • 1
  • Denis R. Stanworth
    • 1
  1. 1.Rheumatology and Allergy Research Group Department of ImmunologyThe Medical SchoolVincent Drive, BirminghamUK

Personalised recommendations